Sofia, Bulgaria
Sofia, Bulgaria
SEARCH FILTERS
Time filter
Source Type

Karel Bierman, Global Director Enzymes of Huvepharma, added, "We are pleased to collaborate with Intrexon and anticipate this project will not only serve to investigate feasibility of fungal expression for the target enzyme but also open the door to the potential of this platform for production of other feed enzymes based on this very cost effective system." Utilizing economical fermentation processes, fungal systems are an ideal production platform for enzymes and other feed additives given their high protein yield and substantial secretion capacity. Through the collaboration, Intrexon plans to engineer optimized cell lines to produce the target feed enzyme, and Huvepharma will test their applicability in large-scale production of feed additives.  Based on the results of the program, the companies intend to pursue fermentative production of the target enzyme as well as look for additional commercial opportunities utilizing this platform. The global feed additives market is estimated to exceed $20 billion by 2021 as demand for animal protein continues to increase.  To meet these requirements, the nutritional value and the digestibility of animal feed needs to be improved which requires an efficient industrial production of enzymes and other protein-based additives.  Enzymes used to enhance the nutritional value of feeds were valued at over $1 billion in 2015. About Huvepharma Huvepharma® is a globally operating company, which has expanded throughout the years by intensive internal evolvement and numerous strategic acquisitions with a focus on developing, manufacturing and marketing of human and animal health products. The highly efficient integrated structure and the talented human capital allow our company to offer competitive and beneficial business conditions. Our state-of-the-art production and quality control equipment ensure top quality products and prove our reputation as a highly trusted producer, very flexible in meeting customers' and partners' needs. To explore more and see how "We add performance to your business" please visit www.huvepharma.com. About Intrexon Corporation Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet.  The Company's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells.  We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn. Trademarks Intrexon, Powering the Bioindustrial Revolution with Better DNA, and Better DNA are trademarks of Intrexon and/or its affiliates. Other names may be trademarks of their respective owners. Safe Harbor Statement Some of the statements made in this press release are forward-looking statements.  These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business.  Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release. For more information regarding Huvepharma, contact: Karel Bierman Global Director Enzymes Karel.Bierman@Huvepharma.com  Tel: +32 3 292 8304 For more information regarding Intrexon Corporation, contact: Investor Contact: Christopher Basta Vice President, Investor Relations Tel: +1 (561) 410-7052 investors@intrexon.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/huvepharma-to-utilize-intrexons-proprietary-fungal-expression-platform-to-produce-key-animal-feed-enzyme-300454069.html


Trademark
Huvepharma and Zoetis Llc | Date: 2016-03-01

Veterinary preparations for the treatment and control of coccidiosis in chickens, turkeys, cattle and calves.


Trademark
Huvepharma | Date: 2015-08-11

Pharmaceutical preparations for the prevention and control of gastrointestinal and respiratory diseases; veterinary preparations, namely, medicines for the prevention and control of gastrointestinal and respiratory diseases in livestock; veterinary preparations for the prevention and control of infectious diseases of the gastrointestinal tract; veterinary preparations to maintain growth and improve feed digestibility in the case of pathological conditions in livestock; microorganisms for medical and veterinary use, namely, micro-nutrient preparations for the prevention of gastrointestinal diseases; preparations of microorganisms for medical and veterinary use, namely, micro-nutrient preparations for the prevention of gastrointestinal diseases; ferments for pharmaceutical purposes. Additives to animal feed/fodder not for medical purposes, namely, mash for fattening livestock.


Trademark
Huvepharma | Date: 2016-06-28

Pharmaceutical preparations for the prevention and treatment of gastrointestinal diseases; veterinary preparations, namely, medicines for the prevention of coccidiosis in livestock; veterinary preparations for the prevention and treatment of infectious diseases of the gastrointestinal tract; veterinary preparations for the prevention and treatment of parasitic diseases; veterinary preparations to maintain growth and improve feed digestibility in the case of pathological conditions in livestock; supplements to fodder for veterinary medical purposes; animal feed fodder supplements for veterinary purposes; ferments for pharmaceutical purposes; nutritional additives, namely, animal feed additive for use as a nutritional supplement for medical purposes; dietary supplements for animals. Additives to animal feed, not for medical purposes, namely, mash for fattening livestock.


Trademark
Huvepharma | Date: 2015-12-16

Pharmaceutical preparations for the prevention and treatment of gastrointestinal diseases; veterinary preparations, namely, medicines for the prevention of coccidiosis in livestock; veterinary preparations for the prevention and treatment of infectious diseases of the gastrointestinal tract; veterinary preparations for the prevention and treatment of parasitic diseases; veterinary preparations to maintain growth and improve feed digestibility in the case of pathological conditions in livestock; supplements to fodder for veterinary medical purposes; animal feed fodder supplements for veterinary purposes; ferments for pharmaceutical purposes; nutritional additives, namely, animal feed additive for use as a nutritional supplement for medical purposes; dietary supplements for animals.


Trademark
Huvepharma | Date: 2015-10-08

Flavorings for animal feed made in part from dried essential oils.


Trademark
Huvepharma | Date: 2015-10-23

Flavorings for animal feed made in part from dried essential oils.


News Article | November 23, 2016
Site: www.newsmaker.com.au

Marketstudyreport.Com Adds “Global Tylosin Market by Manufacturers, Regions, Type and Application, Forecast to 2021” New Report To Its Research Database. The Report Spread Across 111 Pages With Table And Figures In It. Tylosin is a macrolide-class broad spectrum antibiotic thats used in veterinary medicine to treat felines, canines and livestock. However, the drug is only used as an antibiotic in the treatment of infections in livestock. In cats, dogs, and other smaller animals, Technology is used predominantly for Technologys anti-inflammatory properties to treat inflammatory condTechnologyions in the bowel. As such, Technology is commonly prescribed to pets that are suffering from diarrhea. Scope of the Report: This report focuses on the Tylosin in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Elanco Huvepharma Tairui Pharmaceuticals Qilu Pharmaceutical (Inner Mongolia) Henan Hualun Top Pharm Chemical Group HISUN Lukang Shelile Pharmaceutical Apeloa Kangyu Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Technologyaly) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America, Middle East and Africa Market Segment by Type, covers Tylosin Tartrate Tylosin Phosphate Tylosin Base Market Segment by Applications, can be divided into Animal Feed AddTechnologyives Animal Drugs Browse Full Table of Contents And Data Tables at https://www.marketstudyreport.com/reports/global-tylosin-market-by-manufacturers-regions-type-and-application-forecast-to-2021/ There are 13 Chapters to deeply display the global Tylosin market. Chapter 1, to describe Tylosin Introduction, product scope, market overview, market opportunTechnologyies, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Tylosin, wTechnologyh sales, revenue, and price of Tylosin, in 2015 and 2016; Chapter 3, to display the competTechnologyive sTechnologyuation among the top manufacturers, wTechnologyh sales, revenue and market share in 2015 and 2016; Chapter 4, to show the global market by regions, wTechnologyh sales, revenue and market share of Tylosin, for each region, from 2011 to 2016; Chapter 5, 6, 7 and 8, to analyze the key regions, wTechnologyh sales, revenue and market share by key countries in these regions; Chapter 9 and 10, to show the market by type and application, wTechnologyh sales market share and growth rate by type, application, from 2011 to 2016; Chapter 11, Tylosin market forecast, by regions, type and application, wTechnologyh sales and revenue, from 2016 to 2021; Chapter 12 and 13, to describe Tylosin sales channel, distributors, traders, dealers, appendix and data source. To Receive Personalized Assistance Write To Us @ [email protected] With The Report Title In The Subject Line Along With Your Questions Or Call Us At +1 866-764-2150


News Article | December 2, 2016
Site: www.newsmaker.com.au

MarketStudyReport.com adds “2017-2022 Global Top Countries Tylosin Market Report" new report to its research database. The report spread across 130 pages with table and figures in it. This report studies Tylosin in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Manufacturers in each country, covering Elanco Huvepharma Tairui Pharmaceuticals Qilu Pharmaceutical (Inner Mongolia) Henan Hualun Top Pharm Chemical Group HISUN Lukang Shelile Pharmaceutical Apeloa Kangyu Browse full table of contents and data tables at  https://www.marketstudyreport.com/reports/2017-2022-global-top-countries-tylosin-market-report/ Market Segment by Countries, this report splits Global into several key Countries, with sales, revenue, market share of top 5 players in these Countries, from 2012 to 2017 (forecast), like 1 United States 2 Canada 3 Mexico 4 Germany 5 France 6 UK 7 Italy 8 Russia 9 China 10 Japan 11 India 12 Korea 13 Southeast Asia 14 Australia 15 Brazil 16 Middle East 17 Africa Split by Product Types, with sales, revenue, price, market share of each type, can be divided into Tylosin tartrate Tylosin phosphate Tylosin base Split by applications, this report focuses on sales, market share and growth rate of Tylosin in each application, can be divided into Animal Drugs Animal Food Additives 4 Global Tylosin Manufacturers Profiles/Analysis 4.1 Elanco 4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.1.2 Tylosin Product Types, Application and Specification 4.1.3 Elanco Tylosin Sales, Revenue, Price and Gross Margin (2015 and 2016) 4.1.4 Main Business/Business Overview 4.1.5 Elanco News 4.2 Huvepharma 4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.2.2 Tylosin Product Types, Application and Specification 4.2.3 Huvepharma Tylosin Sales, Revenue, Price and Gross Margin (2012-2017) 4.2.4 Main Business/Business Overview 4.2.5 Huvepharma News 4.3 Tairui Pharmaceuticals 4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.3.2 Tylosin Product Types, Application and Specification 4.3.3 Tairui Pharmaceuticals Tylosin Sales, Revenue, Price and Gross Margin (2012-2017) 4.3.4 Main Business/Business Overview 4.3.5 Tairui Pharmaceuticals News 4.4 Qilu Pharmaceutical (Inner Mongolia) 4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.4.2 Tylosin Product Types, Application and Specification 4.4.3 Qilu Pharmaceutical (Inner Mongolia) Tylosin Sales, Revenue, Price and Gross Margin (2012-2017) 4.4.4 Main Business/Business Overview 4.4.5 Qilu Pharmaceutical (Inner Mongolia) News 4.5 Henan Hualun 4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.5.2 Tylosin Product Types, Application and Specification 4.5.3 Henan Hualun Tylosin Sales, Revenue, Price and Gross Margin (2012-2017) 4.5.4 Main Business/Business Overview 4.5.5 Henan Hualun News 4.6 Top Pharm Chemical Group 4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.6.2 Tylosin Product Types, Application and Specification 4.6.3 Top Pharm Chemical Group Tylosin Sales, Revenue, Price and Gross Margin (2015 and 2016) 4.6.4 Main Business/Business Overview 4.6.5 Top Pharm Chemical Group News 4.7 HISUN 4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.7.2 Tylosin Product Types, Application and Specification 4.7.3 HISUN Tylosin Sales, Revenue, Price and Gross Margin (2012-2017) 4.7.4 Main Business/Business Overview 4.7.5 HISUN News 4.8 Lukang Shelile Pharmaceutical 4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.8.2 Tylosin Product Types, Application and Specification 4.8.3 Lukang Shelile Pharmaceutical Tylosin Sales, Revenue, Price and Gross Margin (2012-2017) 4.8.4 Main Business/Business Overview 4.8.5 Lukang Shelile Pharmaceutical News 4.9 Apeloa Kangyu 4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.9.2 Tylosin Product Types, Application and Specification 4.9.3 Tylosin Sales, Revenue, Price and Gross Margin (2012-2017) 4.9.4 Main Business/Business Overview 4.9.5 Apeloa Kangyu News To receive personalized assistance write to us @ [email protected] with the report title in the subject line along with your questions or call us at +1 866-764-2150

Loading Huvepharma collaborators
Loading Huvepharma collaborators